admin
Director of National Intelligence Tulsi Gabbard has done something a lot of Washington types pretend to like but rarely practice: she opened the blinds. Her team is now investigating more than 120 U.S.-funded biological laboratories overseas — labs that, until now, were shrouded in jargon, grant paperwork and polite denials. Dozens of those facilities are reportedly in Ukraine, and many trace back to Pentagon programs and federal research money that flowed through layers of grantees and subawardees.
What Gabbard Is Actually Investigating
The ODNI review is not a mystery novel — it’s a records audit with real stakes. Officials say the labs span more than 30 countries and include clinical trials and experiments that raise ethical, financial and security questions. The concern is not whether the U.S. “owns” a building overseas, but whether American tax dollars funded risky research, including gain-of-function work, without clear oversight. When money moves through multiple hands, accountability tends to evaporate like fog under a microscope.
Why Gain-of-Function Research Matters
Public health, national security, and plain common sense
Gain-of-function research alters pathogens to study how they might become more contagious or more deadly. Supporters claim it helps prepare us for pandemics. Critics point out the obvious: when you make something more dangerous, there’s a risk it could escape containment. We already have a lot of evidence that federal funding reached controversial labs abroad — including experiments connected to Wuhan that raised alarms. That alone should make Americans demand a full accounting of what was done in our name and why safeguards failed.
Cover-Ups, Excuses, and Who Answers for This
If you’ve heard the phrase “we don’t own or operate” from the last administration, pay attention: ownership is not the same as funding. Saying the U.S. doesn’t own a lab is a neat dodge when the truth is that U.S. money kept some of these places running. That dodge goes hand in hand with the same old Washington playbook — obfuscate, deflect, and hope the next news cycle buries it. Now the question is who will be held accountable: bureaucrats who failed to report, grant managers who looked the other way, or policymakers who celebrated risky science without insisting on clear safety lines?
What Americans Should Expect — And Demand
This investigation is a test. If the review produces paper and polite memos that never see daylight, we’ll have seen another exercise in theater. If it leads to public briefings, audits, prosecutions where warranted, and real reforms to how federal research money is tracked, it will be a step toward restoring trust. The Trump administration’s push for transparency under DNI Gabbard gives Republicans a chance to deliver on promises to rein in dangerous science done on the public dime. Americans should demand full disclosure, stronger oversight, and a simple principle: if the government pays for risky research, the taxpayers deserve to know what was done and why.
